JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Exploring the Scope of Melanoma Educational Content on Instagram

Published online April 25, 2025

The American Cancer Society estimates a 7.3% increase in new melanoma cases in 2024 and a 3.8% rise in mortality. 1 According to SEER ...

read more
Cutaneous Immune-Related Adverse Events Associated With Immunotherapy in Patients With Melanoma

Published online April 23, 2025

BACKGROUND Actinic keratosis (AK) is a prevalent skin lesion induced by ultraviolet (UV) radiation, serving as a precursor to squamous cell carcinom...

read more
Squamous Cell Carcinoma In Situ on High-Risk Sites and With Larger Sizes Require More Stages for Clearance With Mohs Surgery

Published online April 19, 2025

Cutaneous squamous cell carcinoma in situ (SCCis), also known as Bowen's disease, is a common intra-epidermal, low-grade malignancy tha...

read more
Endocrine Mucin Producing Sweat Gland Carcinoma Treated With Mohs Micrographic Surgery: A Systematic Review

Published online April 21, 2025

Endocrine Mucin Producing Sweat Gland Carcinoma (EMPSGC) is a rare, low-grade neuroendocrine cutaneous adnexal neoplasm. This tumor is ...

read more
Successful Treatment of Sacral Pressure Injury With ACU-D1

Published online April 21, 2025

Pressure injuries are exceedingly common lesions which cause a great deal of morbidity, especially in the elderly. 1 Treatment is most...

read more
Synergistic Mechanisms of 5-Fluorouracil and Imiquimod in the Treatment of Actinic Keratoses

Published online April 18, 2025

Actinic keratoses (AK) are common precancerous lesions characterized by rough, scaly patches resulting from chronic sun exposure. With ...

read more
The Impact of Geographic Dermatologist Density on Melanoma Mortality

Published online April 18, 2025

Melanoma is one of the most common malignancies in the United States (US) and has the highest mortality rate of any skin cancer. 1 A s...

read more
All Things Acids: A Primer on Alpha Hydroxy, Beta Hydroxy, and Polyhydroxy Acids

Published online April 11, 2025

Hydroxy acids (HAs) are a diverse class of topical agents with a decades-long tenure in dermatology, used for acne, ichthyosis, keratos...

read more
Evaluating Postoperative Outcomes of Mohs Surgery in the Elderly: A Retrospective Review of Large Repairs

Published online April 9, 2025

As individuals age, morphological and immunological changes affect the skin's function as a protective barrier. These changes not only ...

read more
Surgical Outcomes of Cylindrocarcinoma Treated With Mohs Micrographic Surgery and Excision: A Systematic Review

Published online April 7, 2025

Cylindromas are well-circumscribed, smooth, pink nodular tumors predominantly found on the head and neck regions, frequently associated...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

Journal of Drugs in Dermatology JDD Article About Top Chief Complaints and Diagnoses for Outpatient Dermatology Patients of Color

Top Chief Complaints and Diagnoses for Outpatient Dermatology Patients of Color

| Featured Articles, Latest News, Skin of Color, The Latest | No Comments
Did you miss it? By 2044, people with skin of color (SOC) will make up the majority of the U.S. population—but dermatology still lags behind in addressing their unique needs.…
Journal of Drugs in Dermatology JDD Article About Improvement in Skin Moisturization and Lack of Barrier Damage Following Treatment With Clascoterone Cream 1%

Improvement in Skin Moisturization and Lack of Barrier Damage Following Treatment With Clascoterone Cream 1%

| Acne, Featured Articles, Latest News, The Latest | No Comments
Acne Treatment Without the Dry-Out: Clascoterone Cream 1% Proves Gentle on the Skin Barrier Topical acne meds often come with an unfortunate side effect: dry, irritated skin that leaves patients…

New Innovations with SkinCeuticals Advanced RGN-6

| JDD Highlights, JDD Webinars, The Latest | No Comments
Active ingredients play a critical role in the efficacy and safety of cosmeceuticals. Join Dr. Corey L. Hartman, as he shares information on a new cosmeceutical formulation. This presentation will…
Journal of Drugs in Dermatology JDD Article About The State of the Clinical Management Union: A Cross-Sectional Survey of Persons With Hidradenitis Suppurativa

The State of the Clinical Management Union: A Cross-Sectional Survey of Persons With Hidradenitis Suppurativa

| Acne, Featured Articles, Latest News, The Latest | No Comments
April Issue Must-Read! Hidradenitis suppurativa (HS) isn’t just painful—it’s deeply isolating. And new data reveals why: the majority of people living with HS don’t feel heard, treated, or informed. In a…
Journal of Drugs in Dermatology JDD Article About An Algorithm Integrating Acneceuticals into the Management of Acne Vulgaris

An Algorithm Integrating Acneceuticals into the Management of Acne Vulgaris

| Acne, Featured Articles, Latest News, The Latest | No Comments
Did you miss this #acneceuticals article from April’s issue? What if your acne routine could be smarter, more personalized—and actually stick? Say hello to the new acne algorithm that’s changing…
Journal of Drugs in Dermatology JDD Article About Off-Label Management Strategies for Generalized Granuloma Annulare: What's New?

Off-Label Management Strategies for Generalized Granuloma Annulare: What’s New?

| Featured Articles, Latest News, The Latest | No Comments
Beyond the Granuloma: Rethinking Treatment Strategies for Generalized Granuloma Annulare Long considered a therapeutic challenge, generalized granuloma annulare (GGA) continues to defy many conventional treatment approaches. While topical steroids may…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

Prevention is the Best Medicine: ADing up the Data

| Atopic Dermatitis, CME Activities, Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Dr. Candrice Heath, Dr. Jonathan O’B. Hourihane & Dr. Adam Friedman Continue to CME Activity Atopic Dermatitis (AD) is the second most common chronic inflammatory (coming for…
Tune In

Follow Us